Merck & Co

Merck & Co Asset Growth

The Year-over-Year Total Asset Growth of Merck & Co (MRK) as of Nov 15, 2026 is 16.87 %. In the previous year, Year-over-Year Total Asset Growth was 9.78 % — a change of 72.56% (higher).

Asset Growth

16.87 %

YoY

72.56%

Last updated:

Year-over-Year Total Asset Growth of Merck & Co is 2025 16.87 % . Year-over-Year Total Asset Growth of Merck & Co was 2024 9.78 % . It decreases by 72.56% higher compared to the previous year.

The Merck & Co Asset Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Asset Growth
Date
Asset Growth
Jan 1, 2018
-5.96 USD
Jan 1, 2019
2.13 USD
Jan 1, 2020
8.52 USD
Jan 1, 2021
15.40 USD
Jan 1, 2022
3.28 USD
Jan 1, 2023
-2.28 USD
Jan 1, 2024
9.78 USD
Jan 1, 2025
16.87 USD
The Merck & Co Asset Growth history
YEARAsset GrowthYoY
16.87 %+72.56%
9.78 %-529.54%
-2.28 %-169.42%
3.28 %-78.71%
15.40 %+80.76%
8.52 %+300.06%
2.13 %-135.75%
-5.96 %-24.29%
-7.87 %+27.00%
-6.20 %-273.29%
3.58 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Merck & Co Stock analysis

What does Merck & Co do? The company Merck & Co Inc has a long history. It was founded in 1891 by the German pharmacist Friedrich Jacob Merck and is now based in Kenilworth, New Jersey, USA. The company has evolved over time into a globally operating company in the pharmaceutical and chemical industry. Merck & Co Inc's business model is based on the development, production, and marketing of medicines and products for the healthcare industry. The company collaborates with other partners such as universities, other companies, and governments to achieve the best possible scientific progress. Research and development play a very important role in this. Merck is divided into three main areas: The Human Health division, which specializes in the development of prescription drugs and products to improve human health. The second division is Animal Health, which focuses on animal medicines and care products. The third division, Life Science (formerly MilliporeSigma), is dedicated to the development of products and services for biopharmaceutical research and production to facilitate the discovery and manufacturing of medicines. Merck & Co Inc. offers a wide range of products, ranging from prescription medicines to specialty chemicals. Some of the most well-known drugs include Januvia for the treatment of type 2 diabetes and Keytruda, an immuno-oncology drug used in the treatment of various types of cancer. Other well-known drugs from Merck & Co Inc. include Gardasil for the prevention of HPV infections, Propecia for the treatment of male pattern hair loss, and Zetia for the treatment of high cholesterol. The company is extremely innovative and has made significant advances in pharmaceutical research in recent decades. Merck & Co Inc. has won numerous awards over the years, including the "2018 Australian Financial Review Boss Most Innovative Companies Award" and the "2018 Global Energy Award for Technology Innovation". Merck & Co Inc. operates worldwide and has subsidiaries and partnerships in many countries. The company has about 69,000 employees and distributes its products in over 140 countries. Merck & Co Inc.'s products are typically prescription-only and prescribed by doctors and professionals. Overall, Merck & Co Inc. is a company with an impressive history that is now one of the leading companies in the pharmaceutical and chemical industry. Thanks to its innovation and its consistent focus on the needs of patients and healthcare professionals, it is able to successfully meet challenges in the healthcare industry and set new standards. Merck & Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Merck & Co stock

Year-over-Year Total Asset Growth of Merck & Co is 16.87 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Total Asset Growth Merck & Co since 2006 – with annual values, charts, and detailed analysis.

Asset growth measures the percentage change in total assets. Rapid asset growth may indicate expansion but can also correlate with lower future returns.

To evaluate Year-over-Year Total Asset Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Total Asset Growth.

Year-over-Year Total Asset Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Total Asset Growth's Merck & Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Merck & Co

All Key Metrics — Merck & Co